Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries

Health Policy

Volumn 85, Issue 3, 2008, Pages 305-313

  Garattini, Livio ^a   Motterlini, Nicola ^a   Cornago, Dante ^a  

^a MARIO NEGRI INST PHARMACOL RES   (Italy)

Author keywords

Distribution margins; Europe; Pharmaceuticals; Prices

Indexed keywords

ARTICLE; BELGIUM; DRUG COST; DRUG MARKETING; FRANCE; GERMANY; HOSPITAL PATIENT; ITALY; NETHERLANDS; PHARMACY; REIMBURSEMENT; SPAIN; TAX; UNITED KINGDOM;

COMMERCE; EUROPE; HUMANS; INPATIENTS; MODELS, ECONOMIC; PHARMACEUTICAL PREPARATIONS;

EID: 38749115784     PISSN: 01688510     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healthpol.2007.08.005     Document Type: Article

References (14)

1. OECD Health Data 2003, 3rd ed.
2. de Joncheere K., Haaijer-Ruskamp F.M., Rietveld A.H., and Dukes M.N.G. Scope of the problem. International Journal of Risk and Safety of Medicine 15 (2002) 7-13
3. Martikainen J., Kivi I., and Linnosmaa I. European prices of newly lanched reimbursable pharmaceuticals-a pilot study. Health Policy 74 3 (2005) 235-246
4. Ess S.M., Schneeweiss S., and Szucs T.D. European healthcare policies for controlling drug expenditure. Pharmacoeconomics 21 2 (2003) 89-103
5. Rietveld A.H., and Haaijer-Ruskamp F.M. Policy options for cost containment of pharmaceuticals. International Journal of Risk and Safety of Medicine 15 (2002) 29-54
6. Garattini L., Cornago D., and De Compadri P. Pricing and reimbursement of in-patent drugs in seven European countries: a comparative analysis. Health Policy 82 (2007) 330-339
7. Garattini L., Salvioni F., Scopelliti D., and Garattini S. A comparative analysis of the pharmaceutical market in four European countries. Pharmacoeconomics 6 5 (1994) 417-423
8. Danzon P.M., and Kim J.D. International price comparisons for pharmaceuticals. Measurement and policy issues. Pharmacoeconomics 14 Suppl. 1 (1998) 115-128
9. Danzon P.M., and Chao L.-W. Cross national price differences for pharmaceuticals, how large and why?. Journal of Health Economics 19 (2000) 159-195
10. Anderson F. Methodological aspects of international drug price comparison. Pharmacoeconomics 4 4 (1993) 247-256
11. Danzon P.M., and Furukawa M.F. Prices and availability of pharmaceuticals: evidence from nine countries. Health Affairs 22 6 (2003) W521-W536
12. Garattini L., and Tediosi F. A comparative analysis of generics markets in five European countries. Health Policy 51 3 (2000) 149-162
13. Ufficio italiano dei cambi: http://www.uic.it.
14. Eurostat: http://epp.eurostat.ec.europa.eu.